11/15
09:08 am
mrsn
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock.
High
Report
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock.
8/27
10:38 am
mrsn
Rating for MRSN
Low
Report
Rating for MRSN
8/27
10:38 am
mrsn
Rating for MRSN
Low
Report
Rating for MRSN